Allogeneic Marrow Transplant

Also known as: Allogeneic bone marrow transplant / Allogenic bone marrow transplantation therapy / Allogeneic bone marrow transplantation / Allogenic Bone Marrow Transplantation / Allogeneic bone marrow transplantation (procedure)

Drug	Drug Name	Drug Description
DB00020	Sargramostim	A modified form of recombinant human granulocyte-macrophage colony stimulating factor used to increase immune cell production after myelosuppressive therapy or bone marrow transplant.

Drug	Drug Name	Target	Type
DB00020	Sargramostim	Granulocyte-macrophage colony-stimulating factor receptor subunit alpha	target
DB00020	Sargramostim	Bone marrow proteoglycan	target
DB00020	Sargramostim	Interleukin-3 receptor subunit alpha	target
DB00020	Sargramostim	Cytokine receptor common subunit beta	target
DB00020	Sargramostim	Syndecan-2	target

Drug	Drug Name	Phase	Status	Count
DB01008	Busulfan	2	Completed	1
DB00099	Filgrastim	2	Completed	1
DB01073	Fludarabine	2	Completed	1
DB01042	Melphalan	2	Completed	1
DB00635	Prednisone	2	Recruiting	1
DB00091	Cyclosporine	Not Available	Completed	1